Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Invest Dermatol ; 139(12): 2517-2527.e5, 2019 12.
Article in English | MEDLINE | ID: mdl-31247201

ABSTRACT

Patients with diabetes frequently present with complications such as impaired skin wound healing. Skin wound sites display a markedly enhanced expression of CCL2, a potent macrophage chemoattractant, together with macrophage infiltration during the early inflammatory phase in skin wound healing of healthy individuals, but the association of CCL2 with delayed skin wound healing in patients with diabetes remains elusive. In this study, we showed that, compared with control mice, mice with streptozotocin-induced diabetes displayed impaired healing after excisional skin injury, with decreased neovascularization, CCL2 expression, and macrophage infiltration. Compromised skin wound healing in mice with diabetes was reversed by the administration of topical CCL2 immediately after the injury, as evidenced by normalization of wound closure rates, neovascularization, collagen accumulation, and infiltration of macrophages expressing vascular endothelial growth factor, a potent angiogenic factor, and transforming growth factor-ß. CCL2 treatment further increased the accumulation of endothelial progenitor cells at the wound sites of mice with diabetes and eventually accelerated neovascularization. Thus, the topical application of CCL2 can be an effective therapeutic option for the treatment of patients with diabetes with defective wound repair, promoting neovascularization and collagen accumulation at skin wound sites.


Subject(s)
Chemokine CCL2/administration & dosage , Collagen/metabolism , Diabetes Mellitus, Experimental/drug therapy , Skin/metabolism , Wound Healing/drug effects , Administration, Topical , Animals , Cytokines , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Macrophages/metabolism , Macrophages/pathology , Mice , Neovascularization, Pathologic , Skin/pathology , Treatment Outcome
2.
Int J Biochem Cell Biol ; 44(2): 412-22, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22138225

ABSTRACT

It is known that polyamines increase cell growth through stimulation of the synthesis of several kinds of proteins encoded by the so-called "polyamine modulon". We recently reported that polyamines also increase cell viability at the stationary phase of cell growth through stimulation of the synthesis of ribosome modulation factor, a component of the polyamine modulon. Accordingly, we looked for other proteins involved in cell viability whose synthesis is stimulated by polyamines. It was found that the synthesis of ppGpp regulatory protein (SpoT) and ω protein of RNA polymerase (RpoZ) was stimulated by polyamines at the level of translation. Stimulation of the synthesis of SpoT and RpoZ by polyamines was due to an inefficient initiation codon UUG in spoT mRNA and an unusual location of a Shine-Dalgarno (SD) sequence in rpoZ mRNA. Accordingly, the spoT and rpoZ genes are components of the polyamine modulon involved in cell viability. Reduced cell viability caused by polyamine deficiency was prevented by modified spoT and rpoZ genes whose synthesis was not influenced by polyamines. Under these conditions, the level of ppGpp increased in parallel with increase of SpoT protein. The results indicate that polyamine stimulation of synthesis of SpoT and RpoZ plays important roles for cell viability through stimulation of ppGpp synthesis by SpoT and modulation of RNA synthesis by ppGpp-RpoZ complex.


Subject(s)
DNA-Directed RNA Polymerases/physiology , Escherichia coli Proteins/physiology , Polyamines/pharmacology , Pyrophosphatases/physiology , DNA-Directed RNA Polymerases/biosynthesis , DNA-Directed RNA Polymerases/genetics , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Proteins/biosynthesis , Escherichia coli Proteins/genetics , Gene Expression Regulation, Bacterial , Guanosine Tetraphosphate/metabolism , Microbial Viability/drug effects , Pyrophosphatases/biosynthesis , Pyrophosphatases/genetics , RNA, Bacterial/genetics , RNA, Bacterial/metabolism
3.
J Biol Chem ; 285(37): 28698-707, 2010 Sep 10.
Article in English | MEDLINE | ID: mdl-20628056

ABSTRACT

We searched for proteins whose synthesis is enhanced by polyamines at the stationary phase of cell growth using an Escherichia coli polyamine-requiring mutant in which cell viability is greatly decreased by polyamine deficiency. The synthesis of ribosome modulation factor (RMF) was strongly enhanced by polyamines at the level of translation at the stationary phase of cell growth. In rmf mRNA, a Shine-Dalgarno (SD) sequence is located 11 nucleotides upstream of the initiation codon AUG. When the SD sequence was moved to the more common position 8 nucleotides upstream of the initiation codon, the degree of polyamine stimulation was reduced, although the level of RMF synthesis was markedly increased. Polyamine stimulation of RMF synthesis was found to be caused by a selective structural change of the bulged-out region of the initiation site of rmf mRNA. The decrease in cell viability caused by polyamine deficiency was prevented by the addition of a modified rmf gene whose synthesis is not influenced by polyamines. The results indicate that polyamines enhance cell viability of E. coli at least in part by enhancing RMF synthesis.


Subject(s)
Biogenic Polyamines , Codon, Initiator/metabolism , Escherichia coli Proteins/biosynthesis , Escherichia coli/metabolism , RNA, Bacterial/metabolism , Regulatory Sequences, Ribonucleic Acid/physiology , Ribosomal Proteins/biosynthesis , Biogenic Polyamines/metabolism , Biogenic Polyamines/pharmacology , Codon, Initiator/genetics , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Ribosomal Proteins/genetics
4.
Int Immunopharmacol ; 3(5): 627-42, 2003 May.
Article in English | MEDLINE | ID: mdl-12757733

ABSTRACT

We previously observed that IL-4 gene transduction into a mouse colon 26 adenocarcinoma cell line abrogated its tumorigenicity due to the generation of anti-tumor CTL. DEC-205- and CD11c-double positive cells were increased in the lymph nodes of mice injected with IL-4-transfected cells between 2 and 3 days after the tumor injection, compared with those injected with parental cells. Most of these double positive cells expressed CD86 antigen. Among the chemokines with chemotactic activities against dendritic cells, monocyte chemoattractant protein (MCP)-1/CCL2, ABCD-1/CCL22, and liver and activation-regulated chemokine (LARC)/CCL20 gene expression was enhanced no later than 3 days after the tumor injection, in the draining lymph nodes of IL-4-transfected cell bearing mice. Moreover, gene expression of the receptor for MCP-1/CCL2, CCR2, was enhanced in the draining lymph nodes of the mice injected with IL-4-transfected cells, and most DEC-205-positive cells in the lymph nodes expressed CCR2. Finally, the administration of anti-MCP-1/CCL2 antibodies retarded the rate of tumor regression in mice injected with IL-4-tranfected cells, concomitantly with a decrease in DEC-205- and CD11c-double positive cell number in the draining lymph nodes. Thus, locally produced MCP-1/CCL2 may be responsible for IL-4-mediated tumor rejection presumably based on the induction of dendritic cell migration into the draining lymph nodes.


Subject(s)
Adenocarcinoma/immunology , Chemokine CCL2/physiology , Colonic Neoplasms/immunology , Dendritic Cells/physiology , Interleukin-4/physiology , Lymph Nodes/cytology , T-Lymphocytes, Cytotoxic/immunology , Animals , Antibodies/chemistry , Antibodies/immunology , Cell Line, Tumor , Cell Movement , Chemokines/biosynthesis , Female , Flow Cytometry , Granulocyte-Macrophage Colony-Stimulating Factor , Immunohistochemistry , Interleukin-4/genetics , Mice , Mice, Inbred BALB C , Receptors, Chemokine/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Transfection
5.
Lab Invest ; 82(5): 571-83, 2002 May.
Article in English | MEDLINE | ID: mdl-12003998

ABSTRACT

TNF-alpha has pleiotropic functions, but its role in liver fibrosis has not yet been clarified. To understand the pathophysiologic role of the TNF-alpha/TNF receptor (TNFR) p55 signals in liver fibrosis, 10 mg/kg of dimethylnitrosamine, a specific hepatotoxicant, was administered twice a week into the peritoneal cavity of both TNFRp55 knock-out (KO) and wild-type mice, and the severity of fibrosis was monitored histologically and biochemically. In wild-type mice, histologic analysis demonstrated evident fibrotic changes 1 week after the initiation of dimethylnitrosamine administration, consistent with increased liver collagen contents. Concomitantly, the numbers of Kupffer cells and activated hepatic stellate cells (HSCs) were increased in liver tissue. On the contrary, fibrotic changes were attenuated and the numbers of Kupffer cells and HSCs were decreased in TNFRp55-KO mice. Moreover, gene expression of TNF-alpha and monocyte chemoattractant protein-1, which are involved in Kupffer cell activation or migration, was decreased in the liver of TNFRp55-KO mice. Collectively, TNFRp55-mediated signals may regulate activation of Kupffer cells and HSCs and eventually enhance fibrotic process.


Subject(s)
Antigens, CD/metabolism , Liver Cirrhosis, Experimental/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Animals , Antigens, CD/genetics , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Collagen/drug effects , Collagen/metabolism , DNA Primers/chemistry , Dimethylnitrosamine/toxicity , Female , Gene Expression/drug effects , Kupffer Cells/metabolism , Kupffer Cells/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver Cirrhosis, Experimental/genetics , Liver Cirrhosis, Experimental/pathology , Matrix Metalloproteinases/metabolism , Mice , Mice, Inbred BALB C , Mice, Knockout , RNA, Messenger/analysis , Receptors, Tumor Necrosis Factor/deficiency , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Specific Pathogen-Free Organisms , Tissue Inhibitor of Metalloproteinases/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...